Clinical Trial Supplies Market Analysis By Phase (Phase I, Phase II, Phase III), By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management), By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2014 - 2025

Published: Jul, 2017 | Pages: 95 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global clinical trial supplies market is expected to reach USD 3.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness growth at 7.3% CAGR owing to Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are the primary driver of the industry. Furthermore, geographic expansion and development of Information Technology (IT) to facilitate higher integration and smooth performance of activities are other vitally impacting parameters. Over the next eight years, the clinical trials and pharmaceutical industry is anticipated to continue steady growth, thereby promoting the high requirement of clinical trial supplies.

U.S and Canada are home to majority of clinical trials which are conducted in this region. No language barrier is one of the major factor for the preference of this region for majority of clinical trials, as English language is widely spoken in this region. Major CRO's and biopharmaceutical companies have their hub in this region and with advancement in technology the demand for efficient supplies are increasing and the region is expected to dominate the clinical trial supplies market over the forecast period.

Further Key Findings From the Study Suggest:

• On the basis of clinical phase, the market is anticipated to be dominated by Phase III in 2025. The presence of large number of molecule estimated to reach Phase III by 2020 is the primary factor responsible for this prediction.

• By services, storage and distribution is anticipated to witness the fastest growth at a CAGR of over 7.0%.

• Key end-users of this industry are pharmaceuticals, and biologics. Biologics are expected to witness fastest growth owing to the increasing research in the field of genetics and biotechnology such as development of nanoparticle based drug delivery systems.

• In terms of therapeutic use or clinical indication, oncology dominates the market. The highest research activity as of 2016 is being performed for this indication, which in turn is expected to drive the market.

• Few of the industry players include Movianto GmbH, Thermo Fischer Scientific, Sharp Packaging Services, Catalent Pharma Solution, Biocair International Ltd., PCI Services, Almac Group Ltd, and Patheon Inc. Other players present in the market space include Clinigen Group Plc, Merck Serono, and Chimerix.

 Table of Contents

Chapter 1. Methodology and Scope
                  1.1. Information Procurement
                       1.1.1. Purchased Database
                       1.1.2. GVR's Internal Database
                  1.2. Data Analysis
                  1.3. Market Formulation & Validation
                  1.4. Approaches for Market Estimation

Chapter 2. Executive Summary
                  2.1. Market Snapshot

Chapter 3. Clinical Trial Supplies Market Variables, Trends & Scope
                  3.1. Market Segmentation & Scope
                  3.2. Market Driver Analysis
                  3.3. Penetration & Growth Prospect Mapping
                  3.4. SWOT Analysis, by Factor
                       3.4.1. Political
                       3.4.2. Economic
                       3.4.3. Technological
                  3.5. Industry Analysis - Porter's

Chapter 4. Clinical Trial Supplies: Clinical Phase Estimates & Trend Analysis
                  4.1. Clinical Trial Supplies Market Share, 2016 & 2025
                  4.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following clinical phase: 
                       4.2.1. Phase I
                            4.2.1.1. Phase I market estimates and forecasts, 2014 to 2025
                       4.2.2. Phase II
                            4.2.2.1. Phase II market estimates and forecasts, 2014 to 2025
                       4.2.3. Phase III
                            4.2.3.1. Phase III market estimates and forecasts, 2014 to 2025
                       4.2.4. Others
                            4.2.4.1. Other phases market estimates and forecasts, 2014 to 2025

Chapter 5. Clinical Trial Supplies: Product & Services Estimates & Trend Analysis
                  5.1. Product & Services Market Share, 2016 & 2025
                  5.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following product & services:
                       5.2.1. Manufacturing
                            5.2.1.1. Manufacturing market estimates and forecasts, 2014 to 2025
                       5.2.2. Storage & Distribution
                            5.2.2.1. Storage & distribution market estimates and forecasts, 2014 to 2025
                       5.2.3. Supply chain management
                            5.2.3.1. Supply chain management market estimates and forecasts, 2014 to 2025
                            5.2.3.2. Cold chain distribution
                                 5.2.3.2.1. Cold chain distribution market estimates and forecasts, 2014 to 2025
                            5.2.3.3. Non-cold chain distribution
                                 5.2.3.3.1. Non-cold chain distribution market estimates and forecasts, 2014 to 2025

Chapter 6. Clinical Trial Supplies: End-Use Estimates & Trend Analysis
                  6.1. Clinical Trial Supplies Market Share, 2016 & 2025
                  6.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following end-users: 
                       6.2.1. Pharmaceuticals
                            6.2.1.1. Pharmaceuticals market estimates and forecasts, 2014 to 2025
                       6.2.2. Biologics
                            6.2.2.1. Biologics market estimates and forecasts, 2014 to 2025
                       6.2.3. Medical Devices
                            6.2.3.1. Medical Devices market estimates and forecasts, 2014 to 2025
                       6.2.4. Others
                            6.2.4.1. Others market estimates and forecasts, 2014 to 2025

Chapter 7. Clinical Trial Supplies: Therapeutic Use Estimates & Trend Analysis
                  7.1. Clinical Trial Supplies Market Share, 2016 & 2025
                  7.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following therapeutic use:
                       7.2.1. Oncology
                            7.2.1.1. Oncology market estimates and forecasts, 2014 to 2025
                       7.2.2. CNS
                            7.2.2.1. CNS market estimates and forecasts, 2014 to 2025
                       7.2.3. Cardiovascular
                            7.2.3.1. Cardiovascular market estimates and forecasts, 2014 to 2025
                       7.2.4. Infectious disease
                            7.2.4.1. Infectious Disease market estimates and forecasts, 2014 to 2025
                       7.2.5. Metabolic disorders
                            7.2.5.1. Metabolic disorders market estimates and forecasts, 2014 to 2025
                       7.2.6. Others
                            7.2.6.1. Other therapeutic areas market estimates and forecasts, 2014 to 2025

Chapter 8. Clinical Trial Supplies: Regional Estimates & Trend Analysis
                  8.1. Clinical Trial Supplies Regional Movement Analysis & Market Share, 2016 & 2025
                  8.2. North America
                       8.2.1. U.S.
                            8.2.1.1. U.S. revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
                            8.2.1.2. U.S. revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
                            8.2.1.3. U.S. revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
                            8.2.1.4. U.S. revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
                       8.2.2. Canada
                            8.2.2.1. Canada revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
                            8.2.2.2. Canada revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
                            8.2.2.3. Canada revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
                            8.2.2.4. Canada revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
                  8.3. Europe
                       8.3.1. UK
                            8.3.1.1. UK revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
                            8.3.1.2. UK revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
                            8.3.1.3. UK revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
                            8.3.1.4. UK revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
                       8.3.2. Germany
                            8.3.2.1. Germany revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
                            8.3.2.2. Germany revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
                            8.3.2.3. Germany revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
                            8.3.2.4. Germany revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
                  8.4. Asia Pacific
                       8.4.1. Japan
                            8.4.1.1. Japan revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
                            8.4.1.2. Japan revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
                            8.4.1.3. Japan revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
                            8.4.1.4. Japan revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
                       8.4.2. China
                            8.4.2.1. China revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
                            8.4.2.2. China revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
                            8.4.2.3. China revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
                            8.4.2.4. China revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
                  8.5. Latin America
                       8.5.1. Brazil
                            8.5.1.1. Brazil revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
                            8.5.1.2. Brazil revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
                            8.5.1.3. Brazil revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
                            8.5.1.4. Brazil revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
                       8.5.2. Mexico
                            8.5.2.1. Mexico revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
                            8.5.2.2. Mexico revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
                            8.5.2.3. Mexico revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
                            8.5.2.4. Mexico revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
                  8.6. MEA
                       8.6.1. South Africa
                            8.6.1.1. South Africa revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
                            8.6.1.2. South Africa revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
                            8.6.1.3. South Africa revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
                            8.6.1.4. South Africa revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
                       8.6.2. Saudi Arabia
                            8.6.2.1. Saudi Arabia revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
                            8.6.2.2. Saudi Arabia revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
                            8.6.2.3. Saudi Arabia revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
                            8.6.2.4. Saudi Arabia revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)

Chapter 9. Competitive Landscape
                  9.1. Strategy Framework
                  9.2. Company Profiles
                       9.2.1. Almac Group Ltd.
                            9.2.1.1. Company Overview
                            9.2.1.2. Financial Performance
                            9.2.1.3. Product Benchmarking
                            9.2.1.4. Strategic Initiatives
                       9.2.2. Biocair International Ltd.
                            9.2.2.1. Company Overview
                            9.2.2.2. Financial Performance
                            9.2.2.3. Product Benchmarking
                            9.2.2.4. Strategic Initiatives
                       9.2.3. Catalent Pharma Solutions
                            9.2.3.1. Company Overview
                            9.2.3.2. Financial Performance
                            9.2.3.3. Product Benchmarking
                            9.2.3.4. Strategic Initiatives
                       9.2.4. KLIFO A/S
                            9.2.4.1. Company Overview
                            9.2.4.2. Financial Performance
                            9.2.4.3. Product Benchmarking
                            9.2.4.4. Strategic Initiatives
                       9.2.5. Movianto GmbH
                            9.2.5.1. Company Overview
                            9.2.5.2. Financial Performance
                            9.2.5.3. Product Benchmarking
                            9.2.5.4. Strategic Initiatives
                       9.2.6. PCI Services
                            9.2.6.1. Company Overview
                            9.2.6.2. Financial Performance
                            9.2.6.3. Product Benchmarking
                            9.2.6.4. Strategic Initiatives
                       9.2.7. Patheon, Inc.
                            9.2.7.1. Company Overview
                            9.2.7.2. Financial Performance
                            9.2.7.3. Product Benchmarking
                            9.2.7.4. Strategic Initiatives
                       9.2.8. PAREXEL International Corporation
                            9.2.8.1. Company Overview
                            9.2.8.2. Financial Performance
                            9.2.8.3. Product Benchmarking
                            9.2.8.4. Strategic Initiatives
                       9.2.9. Sharp Packaging Services
                            9.2.9.1. Company Overview
                            9.2.9.2. Financial Performance
                            9.2.9.3. Product Benchmarking
                            9.2.9.4. Strategic Initiatives
                       9.2.10. Thermo Fischer Scientific, Inc.
                            9.2.10.1. Company Overview
                            9.2.10.2. Financial Performance
                            9.2.10.3. Product Benchmarking
                            9.2.10.4. Strategic Initiatives

List of Tables

1. North America clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
2. North America clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
3. North America clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
4. North America clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
5. North America clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
6. U.S. clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
7. U.S. clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
8. U.S. clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
9. U.S. clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
10. U.S. clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
11. Canada clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
12. Canada clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
13. Canada clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
14. Canada clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
15. Canada clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
16. Europe clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
17. Europe clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
18. Europe clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
19. Europe clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
20. Europe clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
21. UK clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
22. UK clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
23. UK clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
24. UK clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
25. UK clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
26. Germany clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
27. Germany clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
28. Germany clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
29. Germany clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
30. Germany clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
31. Germany clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
32. Asia Pacific clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
33. Asia Pacific clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
34. Asia Pacific clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
35. Asia Pacific clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
36. Asia Pacific clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
37. Japan clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
38. Japan clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
39. Japan clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
40. Japan clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
41. China clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
42. China clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
43. China clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
44. China clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
45. Latin America clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
46. Latin America clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
47. Latin America clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
48. Latin America clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
49. Brazil clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
50. Brazil clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
51. Brazil clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
52. Brazil clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
53. Mexico clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
54. Mexico clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
55. Mexico clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
56. Mexico clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
57. MEA clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
58. MEA clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
59. MEA clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
60. MEA clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
61. South Africa clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
62. South Africa clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
63. South Africa clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
64. South Africa clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
65. Saudi Arabia clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
66. Saudi Arabia clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
67. Saudi Arabia clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
68. Saudi Arabia clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)